Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer    crawled date : 2021 - 04 - 10    save search
Mirati Therapeutics Presents Preclinical Data on Novel Approach to PRMT5 Inhibition that Selectively Targets the PRMT5/MTA Complex in MTAP-Deleted Cancer Models
Published: 2021-04-10 (Crawled : 20:20) - prnewswire.com
MRTX | $58.7 -0.17% 0.34% 0 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
cancer preclinical pre-clinical
Oncocyte Presents New Data at 2021 American Association for Cancer Research Annual Meeting Demonstrating Potential for Pan-Cancer Utility of DetermaIO™
Published: 2021-04-10 (Crawled : 20:20) - globenewswire.com
OCX | News J | $2.495 -2.54% -2.61% 50K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
potential cancer research
PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021
Published: 2021-04-10 (Crawled : 20:20) - globenewswire.com
PMVP | $1.61 -0.62% -0.62% 480K twitter stocktwits trandingview |
Commercial Services
 | Email alert Add to watchlist
cancer research preclinical pre-clinical
MEI Pharma Reports Preclinical Data Demonstrating Ability of Voruciclib to Regulate MYC and Synergize with KRAS Inhibitors in KRAS Mutant Cancers
Published: 2021-04-10 (Crawled : 16:20) - prnewswire.com
MEIP | $3.3 1.54% 1.52% 26K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
cancer preclinical pre-clinical
ESSA Pharma Presents Preclinical Data Supporting the Therapeutic Potential of EPI-7386 at the 2021 American Association of Cancer Research (AACR) Annual Meeting
Published: 2021-04-10 (Crawled : 16:20) - prnewswire.com
EPIX | $6.57 -2.23% -2.28% 100K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
potential cancer research preclinical pre-clinical
Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting
Published: 2021-04-10 (Crawled : 16:20) - prnewswire.com
SYBX | $1.815 -0.82% -0.83% 54K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
phase 1 cancer research trial phase 3 phase 2
Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained Inhibition of Tumor Growth in Multiple Cancers at AACR Annual Meeting 2021
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
KRON | $0.99 -3.88% -4.04% 120K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
cancer growth preclinical pre-clinical
NextCure Presents Preclinical Data for NC762 at American Association for Cancer Research (AACR) Annual Meeting 2021
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
NXTC | $1.67 6.37% 5.99% 62K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
cancer research preclinical pre-clinical
Codiak Presents Data at AACR 2021 Demonstrating Potential of Engineered Exosomes to Enhance the Therapeutic Index of Well-Validated Cancer Immunotherapy Pathways
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
CDAK | $0.057 -55.99% -131.25% 0 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
immunotherapy potential therapy cancer
NuCana Announces Five Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
NCNA | $3.81 0.53% 0.52% 33K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation cancer research
Advaxis Presents Translational Biomarker Data from Ongoing ADXS-503 Phase 1/2 Lung Cancer Trial at the American Associated for Cancer Research (AACR) 2021 Annual Meeting
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
ADXS | $0.57 12.48% 9.5K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
lung cancer ongoing phase 1 cancer research trial phase 3 phase 2 biomarkers
Jounce Therapeutics Presents Preclinical Data from JTX-8064/LILRB2 Program at the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
JNCE | $1.88 -2.59% -1.85% 0 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
GILD | $66.77 0.92% 0.91% 11M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
cancer research preclinical pre-clinical
Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at the American Association for Cancer Research Annual Meeting 2021
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
VINC | $0.8475 -5.83% -6.19% 350K twitter stocktwits trandingview |
| Email alert Add to watchlist
cancer drug research preclinical pre-clinical
HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
HOOK | $0.7317 -4.34% -4.54% 420K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
immunotherapy phase 1 positive therapy cancer phase 3 phase 2
Theratechnologies Presents New In Vivo Pre-Clinical Data at AACR Demonstrating Significant Anti-Tumor Activity of TH1902 in All Studied Cancer Types
Published: 2021-04-10 (Crawled : 16:20) - globenewswire.com
THTX | $1.29 -12.78% 8.1K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
pre-clinical cancer preclinical
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance
EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services
NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services
INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.